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Abstract
Background:  In mouse the cytokine interleukin-7 (IL-7) is required for generation of B
lymphocytes, but human IL-7 does not appear to have this function. A bioinformatics approach was
therefore used to identify IL-7 receptor related genes in the hope of identifying the elusive human
cytokine.
Results:  Our database search identified a family of nine gene candidates, which we have
provisionally named fibronectin immunoglobulin leucine-rich repeat (FIGLER). The FIGLER 1–9 genes are
predicted to encode type I transmembrane glycoproteins with 6–12 leucine-rich repeats (LRR), a
C2 type Ig domain, a fibronectin type III domain, a hydrophobic transmembrane domain, and a
cytoplasmic domain containing one to four tyrosine residues. Members of this multichromosomal
gene family possess 20–47% overall amino acid identity and are differentially expressed in cell lines
and primary hematopoietic lineage cells. Genes for FIGLER homologs were identified in macaque,
orangutan, chimpanzee, mouse, rat, dog, chicken, toad, and puffer fish databases. The non-human
FIGLER homologs share 38–99% overall amino acid identity with their human counterpart.
Conclusion: The extracellular domain structure and absence of recognizable cytoplasmic signaling
motifs in members of the highly conserved FIGLER gene family suggest a trophic or cell adhesion
function for these molecules.
Background
Interleukin-7 (IL-7) is a non-redundant cytokine required
for the generation of B and T lineage cells in mice [1-5].
Although IL-7 is essential for T cell development in
humans, human B cell development is unaffected by the
absence of IL-7 or its receptors [6-8]. Despite extensive
research, the predicted IL-7 equivalent for human B lym-
phopoiesis has so far eluded identification. An important
clue, provided by recent studies showing that human
hematopoietic progenitors develop into mature B cells
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after transplantation in immunodeficient mice, suggests
that the molecules essential for human B cell develop-
ment are either present in the mouse or can be provided
by the transplanted human cells [9,10]. In seeking a
human B lymphopoietic cytokine/receptor pair, we rea-
soned that novel or orphan human receptors with struc-
tural features resembling those of the IL-7 receptor would
be good candidates. A common feature of many cytokine
receptors is the presence of Ig domains, fibronectin (FN)
type III domains, and potential signaling capability [11].
Ig domains define members of the Ig superfamily, which
is the largest family of mammalian cell surface molecules,
comprising approximately half of the leukocyte cell sur-
face glycoproteins [12]. FNIII domains are often found in
molecules with adhesive function and can act as a spacer
to ensure the correct positioning of functional sites [13].
Using bioinformatic searches for transmembrane proteins
with Ig domains, FNIII domains, and signaling potential,
nine human genes were identified that fulfilled the search
criteria. These encode type I transmembrane glycopro-
teins, with 6–12 leucine-rich repeats (LRRs), one C2 Ig
domain, one FNIII domain, a transmembrane domain,
and a tyrosine containing cytoplasmic domain. The genes
have been provisionally named fibronectin immunoglobulin
leucine-rich repeat (FIGLER) 1–9. In contrast to the known
cytokine receptors, the predicted FIGLER molecules have
a unique domain structure, marked by the N-terminal
LRRs and an unusual genomic organization. Two previ-
ously described molecules that combine LRR, Ig and FNIII
domains with unknown signaling capacities and function
are included in this family, namely the photoreceptor-
associated LRR superfamily member (PAL) and the neuro-
nal leucine-rich repeat protein 3 (NLRR3) [14-22]. Here,
we describe the features and expression patterns of the
human FIGLER family members and identify multiple
non-human orthologs.
Results
Identification of human FIGLER genes
Over 3000 nucleotide and amino acid sequences of hypo-
thetical proteins, as defined by the NCBI database, were
analyzed by SMART and BLAST to determine domain
structure and sequence similarity to known molecules.
The initial screening of the human NCBI Genome Data-
base led to the identification of a hypothetical gene that
was predicted to encode a protein with IL-7 receptor-like
structure in that it possessed both Ig and FNIII domains.
The predicted amino acid sequence was then used to
search NCBI's BLAST protein database, leading to the
identification of eight other related molecules in humans
(Figure 1 and Table 1). Based on analysis using the SMART
Human FIGLER molecules Figure 1
Human FIGLER molecules. Schematic representation of human FIGLER molecules 1–9 detailing extracellular motifs and 
intracellular tyrosines. LNT, N-terminal leucine-rich repeat; L, leucine-rich repeat; LCT, C-terminal leucine-rich repeat; Ig, C2 
type Ig domain; FN, FN type III domain.BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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database, each of these proteins is predicted to contain 6–
12 LRR, one C2 Ig domain, one FNIII region, one hydro-
phobic transmembrane region and one to four cytoplas-
mic tyrosines. These molecules were provisionally named
fibronectin immunoglobulin leucine-rich repeat
(FIGLER) 1–9. Although the FIGLER genes are dispersed
in the genome, the predicted amino acid sequences of the
nine FIGLER molecules share 20–47% overall amino acid
identity. Tyrosines are present in each of the FIGLER cyto-
plasmic regions, although they are not located within cur-
rently recognizable signaling motifs. Further analysis of
the predicted amino acid sequences indicated that FIGLER
5 and FIGLER 9 correspond to the previously described
NLRR3 and Pal genes [16,21,22].
Cellular expression of human FIGLER
As this study was directed initially toward identification of
genes that might influence human B lymphopoiesis, RT-
PCR analysis of FIGLER gene expression was performed
on fetal bone marrow B lymphocyte subpopulations,
bone marrow stromal cell lines, fetal thymus, and the
non-B cell fraction in bone marrow. PCR products were
cloned and sequenced to confirm their identity (data not
shown). FIGLER 9 (Pal) served as a negative control gene
in these experiments, as it was previously shown to be ret-
ina-specific (Figure 2A) [16]. The analysis indicated that
FIGLER 1,2,3, and 5 mRNA transcripts were expressed in
primary B lineage cells. FIGLER 1 expression began at the
immature sIgM+ B cell stage. FIGLER 2 expression was
detected at low levels in pro-B cells and in the
CD34+CD19-  cells, a heterogeneous population that
includes hematopoietic stem cells. FIGLER 3 expression
was initiated at the pro-B cell stage, and FIGLER 5 expres-
sion began at the pre-B cell stage. FIGLER 1 and 5 were
also expressed by non-B lineage BM cells. Only FIGLER 2
was found to be expressed in human stromal cell lines.
Analysis of FIGLER expression in hematopoietic cells and cell lines Figure 2
Analysis of FIGLER expression in hematopoietic cells and cell lines. (A) RT-PCR analysis of human FIGLER 1–5 mRNA 
transcripts. Panel 1, primary bone marrow B lineage cells: CD34+CD19-, hemopoietic stem cells and other early hemopoietic 
cells; CD34+CD19+, pro-B cells; CD34-CD19+IgM-, pre-B cells; and CD34-CD19+IgM+ B cells. Panel 2, bone marrow-derived 
stromal cell lines. Panel 3, primary thymus and bone marrow non-B lineage cells. (B) RT-PCR analysis of FIGLER 1, 2 and 9 
mRNA transcripts in human pro-B (REH, Nalm16), pre-B (697, 207, OBS), B (Ramos, Daudi, Raji), T (Jurkat), myeloid (THP-1, 
U937, HL-60, KG-1), and erythoid (K562) cell lines. FIGLER 9 (Pal), a retina specific protein, served as a negative control and β-
actin served as a loading control for all these analyses. PCR product identity was confirmed by sequencing as described in the 
Methods section.
Table 1: Percentage amino acid identity. Pairwise analysis of each FIGLER domain was performed using the Megalign CLUSTALW 
method algorithm, with FIGLER 1 serving as the index of comparison. Percent amino acid identities are indicated and aligned in 
relation to the FIGLER 1 domains. The identity percentage scoring employed here did not penalize for shortened cytoplasmic tails or 
the presence of < 8 LRRs.
Amino acid identity (%)
F I G L E R 23456789
L R R5 3 . 13 3 . 62 8 . 13 2 . 16 2 . 23 5 . 05 6 . 62 7 . 9
Ig C2 55.4 36.9 31.8 38.5 64.6 41.5 52.3 32.9
FNIII 48.8 13.4 12.2 17.1 47.6 15.9 54.4 13.0
IC 39.2 6.8 13.2 13.5 29.7 17.6 36.5 11.4
EC 36.3 25.8 19.0 25.6 53.7 29.0 48.4 24.5
Overall 33.0 22.5 20.8 24.4 47.3 25.3 43.6 22.6BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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FIGLER 4,6,7 and 8 could not be detected in any of the
bone marrow-derived cells examined, despite multiple
attempts and the use of three or more different gene-spe-
cific primer pairs per gene. To examine the FIGLER gene
expression pattern further, we analyzed representative
hemopoietic cell lines, B, T, myeloid and erythroid (Figure
2B). The up-regulation of FIGLER 1 expression observed
as a function of normal B cell development was also
observed in representative B lineage cell lines, although
the OB5 pre-B cell line had relatively high levels com-
pared to the normal pre-B cells. FIGLER 1 and 2 were
expressed weakly in the thymus and in the Jurkat T cell
line, whereas they exhibited reciprocal expression patterns
in myeloid cell lines. The K562 erythroid cell line did not
express any of the FIGLER genes. Surprisingly, given their
robust expression in primary cells of bone marrow origin,
FIGLER 3 and 5 were not detected in any of the cell lines
tested, nor were FIGLER 6, 7, and 8 (data not shown). As
the NCBI EST profile database did not contain bone mar-
row or spleen expression data for the FIGLER molecules,
this constitutes the first evidence for expression of these
molecules in the bone marrow and B lineage cells in par-
ticular.
Identification of non-human FIGLER homologs
Putative FIGLER orthologs were found in macaque, chim-
panzee, orangutan, mouse, rat, dog, chicken, toad, and
puffer fish NCBI databases using the BLASTN algorithmic
search for homology to the identified human FIGLER
gene sequences (Tables 2, 3, 4, 5). Hidden Markov model
searching of GenBank led to the identification of five
potential new FIGLER  orthologs in Takifugu rubripes,
although little information is available about these mole-
cules except amino acid sequence (data not shown).
As was the case for their human counterparts, these genes
were found to be located on different chromosomes. All
FIGLER orthologs contained 6–12 LRR, a single C2 type Ig
domain, a FN type III domain, a hydrophobic transmem-
brane domain, and from one to seven cytoplasmic tyro-
sines. The predicted amino acid sequences of the FIGLER
homologs shared 38–99% overall identity with their
human counterpart. Phylogenetic tree analysis was per-
formed to cluster the non-human FIGLER molecules to
their nearest human FIGLER homolog (Figure 3). The
alternative names, chromosomal locations, predicted
amino acid length, and accession numbers of the human
FIGLER and non-human FIGLER molecules are listed in
Tables 6 and 7.
The chromosomal regions of the human and mouse
FIGLER genes were compared to further examine their
relatedness. The positions of neighboring upstream and
downstream genes were found to be highly conserved, but
the regions containing the mouse FIGLER genes were
inverted relative to the orientation of human FIGLER
chromosomal regions. This is illustrated for FIGLER 1 and
mouse FIGLER 1 (Figure 4). By contrast, the non-mouse
FIGLER genes have the same chromosomal orientation as
their human FIGLER counterparts (data not shown).
As the known NLRR3 (FIGLER 5) and Pal (FIGLER 9)
genes have been shown to have an unusual three exon
structure, we analyzed the predicted exon structure of the
entire FIGLER gene family (Figure 5). Most of the human
FIGLER  and non-human FIGLER  genes have the same
atypical 3 exon structure, in which exon 1 contains the 5'
untranslated region; exon 2 encodes the signal peptide,
LRR, Ig domain, and part of the FNIII domain; and exon
3 encodes the remaining FNIII region, transmembrane
region, cytoplasmic tail, and 3' untranslated region.
Human FIGLER 3, 5, and 7, chimpanzee FIGLER 5, mouse
FIGLER 5 and 7, rat FIGLER 8, and dog FIGLER 5 are
encoded by a single exon. Interestingly, chimpanzee and
chicken FIGLER 9 and chicken FIGLER 4 have a more
standard exon organization, in which exon 1 contains the
5'untranslated region, exon 2 encodes the LRRs, exon 3
contains the Ig domain, and exon 4 encodes the FNIII
region, transmembrane domain, cytoplasmic tail and
3'UTR.
Table 2: Percentage amino acid identity comparison of primate with human FIGLER
Amino acid identity with human FIGLER (%)
Species Macaque Pongo (orangutan) Pan (chimpanzee)
F I G L E R 25189
LRR (Number) 100 (8) 99.1 (11) 100 (8) 62.7 (7) 97.7 (5)
Ig C2 98.8 100 100 68.2 100
FNIII 97.6 97.6 98.8 33.7 100
IC (Number of Tyr) 98.7 (2) 100 (2) 98.6 (1) 39.9 (5) 95.7 (2)
EC 99.4 99.7 99.8 49.7 98.7
Entire molecule 99.4 98.6 99.7 47.2 98.4BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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Table 4: Percentage amino acid identity comparison of Tetra and Xenopus with human FIGLER
Amino acid identity with human FIGLER (%)
Species Tetra (puffer fish) Xenopus (African clawed toad)
FIGLER 2 3 8 9 2 3
LRR (Number) 78.7 (8) 74.8 (11) 67.8 (8) 54.3 (6) 68.3 (8) 64.7 (11)
Ig C2 75.8 69.6 63.6 56.5 70.3 69.6
FNIII 74.4 87.8 68.4 70.1 45.0 46.3
IC (Number of Tyr) 42.7 (5) 75.3 (5) 55.0 (2) 41.9 (3) 34.8 (4) 38.5 (7)
EC 77.4 83.1 62.0 49.7 39.0 60.1
Entire molecule 67.1 75.1 63.1 49.6 38.9 59.2
Table 3: Percentage amino acid identity comparison of rodent with human FIGLER
Amino acid identity with human FIGLER (%)
Species Mouse Rat
F I G L E R 1 2 45 6 79 258
LRR (Number) 100 (8) 97.5 (8) 93.5 (6) 80.8 (10) 95.5 (18) 93.4 (12) 81.5 (6) 98.7 (8) 92.6 (10) 66.7 (8)
Ig C2 96.9 96.3 88.2 84.1 95.4 92.6 87.1 96.9 88.2 61.5
FNIII 95.2 98.8 95.1 67.1 98.8 82.9 83.5 93.1 92.8 62.5
IC (Number of Tyr) 85.1 (1) 84.4 (3) 58.3 (3) 76.0 (3) 94.9 (1) 84.0 (3) 67.1 (2) 82.2 (3) 64.4 (3) 41.4 (4)
EC 97.2 97.4 89.6 59.8 96.9 91.4 75.1 95.1 90.0 57.6
Entire molecule 95.8 94.9 56.3 54.0 96.5 87.7 71.6 92.7 87.2 56.5
Table 5: Percentage amino acid identity comparison of dog, cow, and chicken with human FIGLER
Amino acid identity with human FIGLER (%)
Species Dog Cow Chicken
F I G L E R 2581489
LRR (Number) 99.1 (6) 97.9 (5) 60.1 (4) 99.2 (8) 64.4 (2) 97.8 (4) 68.9 (4)
Ig C2 98.4 90.0 59.7 100 84.3 95.5 77.1
FNIII 98.5 94.0 34.4 97.6 64.1 95.0 69.2
IC (Number of Tyr) 88.5 (2) 83.3 (3) 54.2 (6) 78.2 (1) 60.0 (3) 55.6 (1) 32.2 (1)
EC 98.9 95.2 65.5 97.2 52.5 96.0 54.4
Entire molecule 96.1 94.1 62.4 95.1 44.8 94.5 67.9BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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Phylogenetic analysis of the FIGLER family of molecules Figure 3
Phylogenetic analysis of the FIGLER family of molecules. Phylogenetic analysis of the molecule coding amino acid 
sequence region of the FIGLER family members. The CLUSTALW algorithm was used for multiple sequence alignment of 
divergent sequences after the variable length LRR regions were masked out.BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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Discussion
The nine human orphan receptors identified here were
named FIGLER to emphasize their unique combination of
FN, Ig, and LRR domains. The tyrosines present in their
cytoplasmic regions may indicate signaling potential,
although they were not found to be embedded in known
consensus signaling motifs. The FIGLER  genes encode
molecules that share 20–47% amino acid identity and
similar structure despite their widespread distribution in
the genome. Although our initial goal was to identify a
novel IL-7-like receptor, the FIGLER molecules differ from
known cytokine receptors in that they have LRR domains
on the N-terminal end of the protein. The LRRs are char-
acterized by specific leucine and asparagine residue spac-
ing and are found in proteins with diverse functions and
cellular distribution [14,15,17,21,22]. LRRs also are
Table 7: Non-human FIGLER alternative names, chromosomal locations, predicted protein lengths and NCBI GenBank accession 
numbers
Species Gene name 
(FIGLER)
Alternative 
name
Chromosome 
location
Predicted protein length 
(amino acids)
Protein accession 
number
Gallus Gallus 4 - 4 1009 XP_420649
8 - 5 559 XP_421485
9 - 6 884 XP_426489
Tetraodon 
nigroviridis
2 - 10 794 CAF99016
3 - 11 715 CAG06728
8 - 16 574 CAG08917
9 - 17 660 CAF98662
Pongo pygmaeus 5 LRRN3/NLRR-
3
- 708 CAH93434
Pan troglodytes 1 - 19 628 XP_524229
8 - 19 795 XP_512991
9 - 10 775 XP_521533
Canis familiaris 2 - 12 779 XP_538906
5 - 14 708 XP_539523
8 - 1 730 XP_541626
Bos taurus 1 LRFN3 18 628 NM_001076959
Xenopus laevis 2 LOC496079 - 722 AAH87496
3 XNLRR-1 - 718 BAA28530
Table 6: Human and non-human FIGLER alternative names, chromosomal locations, predicted protein lengths and NCBI GenBank 
accession numbers
Species Gene name (FIGLER) Alternative name Chromosome location Predicted protein length 
(amino acids)
Protein accession number
Homo Sapiens 1 LRFN3 19q13.12 628 NP_078785
2 LRFN2 6p21.2 789 NP_065788
3 LRRN1 3p26.2 716 NP_065924
4 FLJ44691 4q25 496 NP_940908
5 LRRN3 7q31.1 708 NP_060804
6 LRFN4 11q13.2 635 NP_076941
7 LRRN5 1q32.1 713 NP_963924
8 LRFN5 14q21.1 719 NP_689660
9 PAL/LRRC21 10q23 623 NP_056428
Macaca fascicularis 2 LRFN2 - 789 BAB39323
Mus musculus 1 LRFN3 7 626 NP_780687
2 mKIAA 1246 17 824 BAC65758
4 - 3 679 XP_143529
5 LRRN3/LRFN5 12 707 NP_034863
6 LRFN4 19 636 NP_700437
7 LRRN2 1 730 AAQ74241
9 - 14 618 NP_666357
Rattus norvegicus 2 - 9q11 804 XP_236914
5 NLRR3 6q21 707 NP_110483
8 - 1q21 766 XP_344875BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
Page 8 of 11
(page number not for citation purposes)
found in other molecules that are expressed by B cells,
such as Toll-like receptors 9 and 10 [23]. As we sought to
identify molecules that could potentially influence
human B lymphopoiesis, FIGLER  expression was ana-
lyzed in hematopoietic and lymphoid tissues. FIGLER 1,3,
and 5 mRNA expression was found to be up-regulated as
a function of human B cell development, whereas FIGLER
2 was expressed throughout development and in non-B
lineage cells.
The identification of FIGLER relatives in macaque, cow,
chimpanzee, orangutan, mouse, rat, dog, chicken, toad
and puffer fish that share 38–99% amino acid identity to
their human counterparts indicates that this is a conserved
gene family. All of the members encode type I transmem-
brane proteins, and each gene is located on a different
chromosome, except for the chimpanzee FIGLER 1 and 8,
which are both located on chromosome 19. Based on
human FIGLER and mouse FIGLER gene chromosomal
analysis, it is likely that the human and non-human
FIGLER genes are homologs that were derived from com-
mon ancestral genes. Intriguingly, the mouse FIGLER
genes are located on inverted chromosomal segments rel-
ative to their human syntenic regions, although FIGLER
genes in other species have the same orientation as their
human counterparts.
Human/mouse homology map for FIGLER 1 Figure 4
Human/mouse homology map for FIGLER 1. The chromosomal locations and transcriptional orientation of the human 
and mouse FIGLER 1 and flanking genes were determined using the NCBI GenBank Mapview Database. Black ovals denote the 
centromere.BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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As the known NLRR3 (FIGLER 5) and Pal (FIGLER 9)
genes have been shown to have an unusual predicted exon
structure, we determined the exon structure of the entire
FIGLER  gene family [16,21,22]. Most of the human
FIGLER  and non-human FIGLER  genes have the same
atypical 3 exon structure, in which exon 1 contains the 5'
untranslated region; exon 2 encodes the signal peptide,
LRR, Ig domain, and part of the FNIII domain; and exon
3 encodes the remaining FNIII region, transmembrane
region, cytoplasmic tail, and 3' untranslated region. Ig
domains are almost universally encoded by a single exon,
which in part is thought to have accounted for their ready
dispersal in the genome and widespread utilization in cell
surface glycoproteins with multiple functions. Human
FIGLER 3, 5, and 7, chimpanzee FIGLER 5, mouse FIGLER
5, mouse FIGLER 7, rat FIGLER 8, and dog FIGLER 5 are
all intronless genes, suggesting their integration into the
genome via reverse transcription. Nevertheless we have
demonstrated cellular expression for all but FIGLER 4 and
6–8, and all of these genes are predicted to encode an
intact open reading frame. Finally, the chimpanzee and
chicken FIGLER 9 genes and chicken FIGLER 4 have a
more typical organization, and the Ig domain is encoded
by a separate exon.
Conclusion
The functions of the FIGLER gene products are presently
unknown. FIGLER 5 and 9 are identical to the previously
identified Pal and NLRR3. Pal is a type 1 transmembrane
protein that is preferentially expressed in the retina, where
it is up-regulated during photoreceptor outer segment
development. As for the other FIGLER family members,
Pal lacks recognizable signaling motifs in its cytoplasmic
tail and is predicted to act as a trophic factor receptor or
adhesion molecule [16]. NLRRs were identified through
screening of a mouse brain cDNA library, and homologs
have been found in Xenopus, rat, and human brain tissue
[18-20,24,25]. All of the NLRR members are expressed
predominately in the central nervous system [24]. Of the
three known mouse NLRRs, only NLRR3 is up-regulated
with brain injury, thereby suggesting its involvement in
injury recognition or repair [26]. While several of the
FIGLER molecules described here are expressed in B line-
age cells and the expression of FIGLER 1, 3, and 5 is devel-
opmentally regulated within this lineage, the possibility
that these molecules are involved in the interaction
between B lineage cells with the supportive bone marrow
microenvironment remains speculative.
Predicted genomic structure and protein product of human and non-human FIGLER molecules Figure 5
Predicted genomic structure and protein product of human and non-human FIGLER molecules. S, Signal Peptide; 
LNT, N-terminal leucine-rich repeat; L, leucine-rich repeat domain; LCT, C-terminal leucine-rich repeat, Ig, C2 type Ig domain; 
FNIII, FN type III domain; TM, hydrophobic transmembrane domain; Y, tyrosine in predicted cytoplasmic domain. Non-human 
FIGLER genes not listed in this schematic have the same three exon structure as human FIGLER 1, 2, 4, 8, and 9.BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
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Methods
Database and search strategies
The nucleotide sequence, amino acid sequence and
domain structure of the human IL-7 receptor α chain
(NM_002185) was used in the basic local alignment
search tool (BLAST) and simple modular architecture
research tool (SMART) database searches for novel IL-7
receptor α chain relatives [27-29]. The National Center for
Biotechnology Information (NCBI), European Molecular
Biology Laboratory (EMBL), Ensembl, and DNA database
in Japan were all queried, including the expressed
sequence tags (EST) and high throughput genomic
sequences (HTGS) databases. The predicted human
FIGLER  sequences were used to identify homologs in
other species using BLASTN algorithmic and hidden
Markov model (HMM) searches of the NCBI and Gen-
Bank databases. HMM hits were filtered through Pfam
according to their domain composition. The NCBI
genome database was used to align the predicted mRNA
sequences to the genomic sequences and determine
intron-exon boundaries. The human BLAST-like align-
ment tool (BLAT) database (University of California at
Santa Cruz) and Megalign CLUSTALW method algorithm
(Windows version 3.12e; DNASTAR, Madison, WI, USA)
were used to design primers and determine amino acid
identity among the newly identified FIGLER molecules.
The molecular coding amino acid sequence region phylo-
genetic tree analysis of the FIGLER molecules as listed in
the GenBank database was conducted using the CLUS-
TALW method algorithm of Megalign [30]. The variable
length LRR regions were masked out during phylogenetic
analysis in order to compensate for sequence length.
Cell lines
Human stromal cell lines included the WW, WWX, and
stromal 8 lines, which were derived from bone marrow
samples in our laboratory. B lineage cell lines were REH
and Nalm 16 (pro B cell); 697, 207, and OB5 (pre B cell);
and Ramos, Daudi, and Raji (B cell). Myeloid cell lines
included THP-1 (monocytic), HL-60 (promyelocytic),
U937, and KG-1 (myelocytic). The Jurkat T cell line and
K562 erythroid cell lines were also used in this analysis.
Human bone marrow and thymus primary cell isolation
Human adult bone marrow was obtained from resected
ribs of healthy renal transplant donors in accordance with
policies established by the University of Alabama at Bir-
mingham Institutional Review Board. The resected ribs
were processed within 24 h of obtainment, and lymphoid
cells were isolated by Ficoll-Hypaque gradient centrifuga-
tion (Mediatech, Herndon, VA, USA). B lineage cells were
isolated from the bone marrow samples using a MACS B
cell Isolation Kit (Miltenyl Biotec, Auburn, CA, USA). The
isolated primary B lineage cells were resuspended in FACS
buffer (FACS buffer: PBS plus 2% FBS) and incubated for
20 min at 4°C with CD34-APC, CD19-PE, and IgM-FITC
labeled antibodies (BD Biosciences, Palo Alto, CA, USA).
The cells were then sorted based on their differential
CD34, CD19, and IgM expression into four B lineage pop-
ulations: CD34+19-, CD34+19+, CD34-19+IgM-, and
CD34-19+IgM+, using a MoFlo instrument (Cytomation,
Fort Collins, CO, USA). Human fetal bone marrow and
thymus samples used for RT-PCR analysis were obtained
in accordance with policies established by the University
of Alabama at Birmingham Institutional Review Board.
Lymphocytes from 12-to 29-week fetal bone marrow and
thymus were obtained by sedimentation at 100 g over a
lymphocyte separation medium for 30 min at room tem-
perature. The cells recovered at the interface were washed
in PBS containing 5% FCS and 2 to 4 × 107 cells. B lineage
cells were isolated from the bone marrow and thymus
samples using a MACS B cell Isolation Kit.
Reverse transcription (RT)-PCR
Total RNA was isolated from isolated populations of pri-
mary fetal bone marrow B lineage cells, primary fetal
thymic T lineage cells, hematopoietic cell lines, and stro-
mal cell lines using TRIzol (Invitrogen, Carlsbad, CA,
USA). cDNA was generated from the isolated mRNA using
Superscript First Strand Synthesis System for RT-PCR, per
the manufacturer's suggestions (Invitrogen). The follow-
ing gene specific primers were used to amplify each gene
via PCR using Platinum Taq DNA Polymerase (Invitro-
gen): FIGLER 1, forward 5'-CTGCTAGGCAACTCAAGC-3'
and reverse 5'-GATAGGCCGCTGATCCG-3'; FIGLER 2,
forward 5'-GCTACTTCTGGCATGTGC-3' and reverse 5'-
ACCACTGTCCTGAGATGT-3'; FIGLER 3, forward 5'-CAG-
TACAGCCCTTGCTG-3' and reverse 5'-CCACATGTAAT-
AGCTTG-3'; FIGLER 4, forward 5'-
CTCGTGGTGACCAGTACT-3' and reverse 5'-AGCTTCT-
GTCACGTCTGC-3'; FIGLER 5, forward 5'-CAGCAAT-
GCTCTCAGTGC-3' and reverse 5'-
TCGAGCACTTTGCGCAG-3'; FIGLER 9, forward 5'-TCT-
CAATGCAGCTGCAGC-3' and reverse 5'-GCTGGCA-
CATCTCAGTTC-3'. Each amplification reaction
underwent an initial denaturation of 94°C for 2.5 min,
followed by 35 cycles of annealing at 55°C for 1 min,
extension at 72°C for 1 min, denaturation at 94°C for 1
min, and a final extension at 72°C for 10 min. The PCR
products were separated by agarose gel electrophoresis,
and their identity was verified via sequencing after cloning
into a TOPO TA pCR2.1 Vector (Invitrogen). DNA
sequencing was accomplished for both strands by the
dideoxy chain termination method using Thermo Seque-
nase (Amersham Biosciences Corp, Piscataway, NJ, USA),
per the manufacturer's suggestions, and an automated
sequencer (LiCor, Lincoln, NE, USA).Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Biology 2007, 5:36 http://www.biomedcentral.com/1741-7007/5/36
Page 11 of 11
(page number not for citation purposes)
Competing interests
The author(s) declares that there are no competing inter-
ests.
Authors' contributions
DLM conducted the primary database searches, analysis,
RT-PCR experiments, and manuscript preparation. CLH
contributed to database searches, analysis, experimental
design, interpretation, and manuscript preparation. PDB
contributed to the experimental design, analysis, interpre-
tation, and manuscript preparation. MDC contributed to
the experimental design, interpretation, and manuscript
preparation. All authors have read and approved the final
manuscript.
Acknowledgements
We thank our University of Alabama at Birmingham colleagues for helpful 
advice, Randall Davis, for providing cell lines, and Larry Gartland, for cell 
sorting expertise. These studies were supported in part by NIH grants 
AI39816 (MDC) and AI48098 (PDB).
References
1. Carvalho TL, Mota-Santos T, Cumano A, Demengeot J, Vieira P:
Arrested B lymphopoiesis and persistence of activated B
cells in adult interleukin 7-/- Mice.  J Exp Med 2001,
194:1141-1150.
2. Grabstein KH, Waldschmidt TJ, Finkelman FD, Hess BW, Alpert AR,
Boiani NE, Namen AE, Morrissey PJ: Inhibition of murine B and T
lymphopoiesis in vivo by an anti-interleukin 7 monoclonal
antibody.  J Exp Med 1993, 178:257-264.
3. Miller JP, Izon D, DeMuth W, Gerstein R, Bhandoola A, Allman D:
The earliest step in B lineage differentiation from common
lymphoid progenitors is critically dependent upon inter-
leukin 7.  J Exp Med 2002, 196:705-711.
4. Valenzona HO, Dhanoa S, Finkelman FD, Osmond DG: Exogenous
interleukin 7 as a proliferative stimulant of early precursor B
cells in mouse bone marrow: efficacy of IL-7 injection, IL-7
infusion and IL-7-anti-IL-7 antibody complexes.  Cytokine 1998,
10:404-412.
5. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Mur-
ray R: Lymphopenia in interleukin (IL)-7 gene-deleted mice
identifies IL-7 as a nonredundant cytokine.  J Exp Med 1995,
181:1519-1526.
6. Prieyl JA, LeBien TW: Interleukin 7 independent development
of human B cells.  Proc Natl Acad Sci USA 1996, 93:10348-10353.
7. Puel A, Leonard WJ: Mutations in the gene for the IL-7 receptor
result in T(-)B(+)NK(+) severe combined immunodeficiency
disease.  Curr Opin Immunol 2000, 12:468-473.
8. Puel A, Ziegler SF, Buckley RH, Leonard WJ: Defective IL7R
expression in T(-)B(+)NK(+) severe combined immunodefi-
ciency.  Nat Genet 1998, 20:394-397.
9. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura
K, Nakahata T: Complete reconstitution of human lym-
phocytes from cord blood CD34+ cells using the NOD/SCID/
gammacnull mice model.  Blood 2003, 102:873-880.
10. Li C, Ando K, Kametani Y, Oki M, Hagihara M, Shimamura K, Habu S,
Kato S, Hotta T: Reconstitution of functional human B lym-
phocytes in NOD/SCID mice engrafted with ex vivo
expanded CD34(+) cord blood cells.  Exp Hematol 2002,
30:1036-1043.
11. Barclay AN, Brown MH, Alex Law SK, McKnight AJ, Tomlinson MG,
van der Merwe PA: The Leucocyte Antigen: Facts Book 2nd edition. Lon-
don: Academic Press; 1997. 
12. Holness CL, Simmons DL: Structural motifs for recognition and
adhesion in members of the immunoglobulin superfamily.  J
Cell Sci 1994, 107:2065-2070.
13. Potts JR, Campbell ID: Fibronectin structure and assembly.  Curr
Opin Cell Biol 1994, 6:648-655.
14. Bormann P, Roth LW, Andel D, Ackermann M, Reinhard E: zfNLRR,
a novel leucine-rich repeat protein is preferentially
expressed during regeneration in zebrafish.  Mol Cel Neurosc
1999, 13:167-179.
15. Fukamachi K, Matsuoka Y, Kitanaka C, Kuchino Y, Tsuda H: Rat neu-
ronal leucine-rich repeat protein-3: cloning and regulation of
the gene expression.  Biochem Biophys Res Commun 2001,
287:257-263.
16. Gomi F, Imaizumi K, Yoneda T, Taniguchi M, Mori Y, Miyoshi K,
Hitomi J, Fujikado T, Tano Y, Tohyama M: Molecular cloning of a
novel membrane glycoprotein, pal, specifically expressed in
photoreceptor cells of the retina and containing leucine-rich
repeat.  J Neurosci 2000, 20:3206-3213.
17. Hayata T, Uochi T, Asashima M: Molecular cloning of XNLRR-1,
a Xenopus homolog of mouse neuronal leucine-rich repeat
protein expressed in the developing Xenopus nervous sys-
tem.  Gene 1998, 221:159-166.
18. Kajava AV: Review: proteins with repeated sequence – struc-
tural prediction and modeling.  J Struct Biol 2001, 134:132-144.
19. Kobe B, Deisenhofer J: The leucine-rich repeat: a versatile bind-
ing motif.  Trends Biochem Sci 1994, 19:415-421.
20. Malim MH, Bohnlein S, Hauber J, Cullen BR: Functional dissection
of the HIV-1 Rev trans-activator–derivation of a trans-domi-
nant repressor of Rev function.  Cell 1989, 58:205-214.
21. Taguchi A, Wanaka A, Mori T, Matsumoto K, Imai Y, Tagaki T,
Tohyama M: Molecular cloning of novel leucine-rich repeat
proteins and their expression in the developing mouse nerv-
ous system.  Brain Res 1996, 35:31-40.
22. Taniguchi H, Tohyama M, Takagi T: Cloning and expression of a
novel gene for a protein with leucine-rich repeats in the
developing mouse nervous system.  Brain Res 1996, 36:45-52.
23. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A: The toll-
like receptor repertoire of human B lymphocytes: inducible
and selective expression of TLR9 and TLR10 in normal and
transformed cells.  Blood 2003, 102:956-963.
24. Andrade MA, Perez-Iratxeta C, Ponting CP: Protein repeats:
structures, functions, and evolution.  J Struct Biol 2001,
134:117-131.
25. Takahashi N, Takahashi Y, Putnam FW: Periodicity of leucine and
tandem repetition of a 24-amino acid segment in the pri-
mary structure of leucine-rich alpha 2-glycoprotein of
human serum.  Proc Natl Acad Sci USA 1985, 82:1906-1910.
26. Ishii N, Wanaka A, Tohyama M: Increased expression of NLRR-3
mRNA after cortical brain injury in mouse.  Brain Res 1996,
40:148-152.
27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local
alignment search tool.  J Mol Biol 1990, 215:403-410.
28. Letunic I, Goodstadt L, Dickens NJ, Doerks T, Schultz J, Mott R, Cic-
carelli F, Copley RR, Ponting CP, Bork P: Recent improvements to
the SMART domain-based sequence annotation resource.
Nucleic acids Res 2002, 30:242-244.
29. Schultz J, Milpetz F, Bork P, Ponting CP: SMART, a simple modu-
lar architecture research tool: identification of signaling
domains.  Proc Natl Acad Sci USA 1998, 95:5857-5864.
30. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving
the sensitivity of progressive multiple sequence alignment
through sequence weighting, position-specific gap penalties
and weight matrix choice.  Nucleic Acids Res 1994, 22:4673-4680.